In addition, normal GC B cells accumulate elevated levels of somatic hypermutation (SHM) for the diversification of BCR immune repertoire (BCR IR), while tumor B cells often proliferate with limited alteration of BCR sequence despite the expression of activation-induced cytidine deaminase (AICDA) [11,12]. The gene discussed is BCR; the disease is neoplasm.